↓ Skip to main content

Dove Medical Press

Cost-Effectiveness Analysis of Spending on Research and Development to Address the Needs for Innovative Therapeutic Products in Indonesia

Overview of attention for article published in Therapeutics and Clinical Risk Management, October 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
52 Mendeley
Title
Cost-Effectiveness Analysis of Spending on Research and Development to Address the Needs for Innovative Therapeutic Products in Indonesia
Published in
Therapeutics and Clinical Risk Management, October 2020
DOI 10.2147/tcrm.s260377
Pubmed ID
Authors

Auliya A Suwantika, Angga P Kautsar, Neily Zakiyah, Rizky Abdulah, Cornelis Boersma, Maarten J Postma

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 8%
Lecturer 3 6%
Student > Bachelor 3 6%
Other 2 4%
Researcher 2 4%
Other 4 8%
Unknown 34 65%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Business, Management and Accounting 3 6%
Social Sciences 3 6%
Nursing and Health Professions 2 4%
Computer Science 2 4%
Other 4 8%
Unknown 34 65%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 June 2021.
All research outputs
#17,297,846
of 25,387,668 outputs
Outputs from Therapeutics and Clinical Risk Management
#926
of 1,323 outputs
Outputs of similar age
#274,517
of 432,252 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#12
of 13 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,252 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.